Zeo ScientifiX, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Dr. Leider no longer serves as a director of ZEO, as provided for therein.
the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.
the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.
Effective June 1, 2024, our board of directors appointed Ian T. Bothwell, the Company’s Chief Financial Officer to serve in the additional position of Interim Chief Executive Officer
Extracted from this filing and checked against the source text.
Dr. Harry Leider departed as Director at Zeo ScientifiX, Inc..
Dr. Leider no longer serves as a director of ZEO, as provided for therein.View on SEC.gov
Dr. Howard Golub departed as Chief Science Officer at Zeo ScientifiX, Inc..
the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.View on SEC.gov
Dr. Harry Leider departed as Chief Executive Officer at Zeo ScientifiX, Inc..
the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.View on SEC.gov
Ian T. Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..
Effective June 1, 2024, our board of directors appointed Ian T. Bothwell, the Company’s Chief Financial Officer to serve in the additional position of Interim Chief Executive OfficerView on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.